Stay updated with breaking news from Stroke Innovation Grants. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/cloudfront-us-east-1.images.arcpublishing.com/gray/UHVEMUL63JHA3N4LOMLGSF6TYA.jpg)
The project, titled “Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer’s disease,” is funded by the National Institute of Neurological Disorders and Stroke Innovation Grants to Nurture Initial Translational Efforts program, or IGNITE.
/cloudfront-us-east-1.images.arcpublishing.com/gray/UHVEMUL63JHA3N4LOMLGSF6TYA.jpg)
The project, titled “Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer’s disease,” is funded by the National Institute of Neurological Disorders and Stroke Innovation Grants to Nurture Initial Translational Efforts program, or IGNITE.